Defence Therapeutics Inc., CA24463V1013

Defence Therapeutics Inc., CA24463V1013

21.09.2022 - 08:03:04

EQS-News: Defence Therapeutics Inc.: BREAKTHROUGH RESULTS WITH ACCUM A1-REPROGRAMMED MSC, MESENCHYMAL STEM CELLS, IN A NOVEL VACCINE CURED 80% OF ANIMALS WITH PRE-ESTABLISHED LYMPHOMA

21.09.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language: English Company: Defence Therapeutics Inc. 1680 - 200 Burrard St V6C3L6 Vancouver

Canada E-mail: info@defencetherapeutics.com Internet: https://defencetherapeutics.com ISIN: CA24463V1013 WKN: A3CN14 Listed: Regulated Unofficial Market in Frankfurt, Stuttgart; Toronto EQS News ID: 1446677 ? End of News EQS News Service

1446677??21.09.2022?CET/CEST

@ dgap.de